Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: Is there a lead-time bias?

By Huo Teh-Ia   Huang Yi-Hsiang   Chiang Jen-Huei   Wu Jaw-Ching   Lee Pui-Ching   Chi Chin-Wen   Lee Shou-Dong  

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 4, 2007-01 ,pp. : 485-492

Informa Healthcare

Access to resources Recommend Favorite

Current and Future Treatment Strategies for Patients with Advanced Hepatocellular Carcinoma: Role of mTOR Inhibition

By  

Liver Cancer, Vol. 1, Iss. 3-4, 2012-11 ,pp. : 247-256

Karger

Access to resources Recommend Favorite

Surgery and Hepatocellular Carcinoma

By  

Liver Cancer, Vol. 6, Iss. 1, 2016-11 ,pp. : 44-50

Karger

Access to resources Recommend Favorite

Three-dimensional conformal radiotherapy for the treatment of arteriovenous shunting in patients with hepatocellular carcinoma

By Hsu H C   Chen T Y   Chiu K W   Huang E Y   Leung S W   Huang Y J   Wang C Y  

British Journal of Radiology, Vol. 80, Iss. 949, 2007-01 ,pp. : 38-42

British Institute of Radiology

Access to resources Recommend Favorite

Systemic Treatment of Hepatocellular Carcinoma

By  

Digestive Diseases, Vol. 19, Iss. 4, 2002-03 ,pp. : 311-323

Karger

Access to resources Recommend Favorite